| |
 |
ARTICLES 
|
|
| Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice? |
| RT Hoppe |
|
JCO Jun 1 1991: 897–901.
[PDF]
|
 |
| Is more better? Dose intensity in neuroblastoma |
| JR Anderson and PF Coccia |
|
JCO Jun 1 1991: 902–904.
[PDF]
|
|
|
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial |
| |
DL Longo, E Glatstein, PL Duffey, RC Young, SM Hubbard, WJ Urba, MN Wesley, A Raubitschek, ES Jaffe, and PH Wiernik |
| |
JCO Jun 1 1991: 906–917.
[Abstract]
[PDF]
|
|
|
Phase I-II studies of yttrium-labeled antiferritin treatment for end- stage Hodgkin's disease, including Radiation Therapy Oncology Group 87- 01 [published erratum appears in J Clin Oncol 1991 Aug;9(8):1516] |
| |
HM Vriesendorp, JM Herpst, MA Germack, JL Klein, PK Leichner, DM Loudenslager, and SE Order |
| |
JCO Jun 1 1991: 918–928.
[Abstract]
[PDF]
|
|
|
Clinical and virologic effects of recombinant human granulocyte- macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial |
| |
LD Kaplan, JO Kahn, S Crowe, D Northfelt, P Neville, H Grossberg, DI Abrams, J Tracey, J Mills, and PA Volberding |
| |
JCO Jun 1 1991: 929–940.
[Abstract]
[PDF]
|
|
|
Effective treatment of small-noncleaved-cell lymphoma with high- intensity, brief-duration chemotherapy |
| |
ML McMaster, JP Greer, FA Greco, DH Johnson, SN Wolff, and JD Hainsworth |
| |
JCO Jun 1 1991: 941–946.
[Abstract]
[PDF]
|
|
|
The prognosis of Hodgkin's disease in older adults |
| |
VF Guinee, GG Giacco, M Durand, JW van den Blink, A Gustavsson, JG McVie, R Zewuster, S Dische, T Fahey, and W Lane |
| |
JCO Jun 1 1991: 947–953.
[Abstract]
[PDF]
|
|
|
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer |
| |
U Sagman, R Feld, WK Evans, D Warr, FA Shepherd, D Payne, J Pringle, J Yeoh, G DeBoer, and A Malkin |
| |
JCO Jun 1 1991: 954–961.
[Abstract]
[PDF]
|
|
|
Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases |
| |
G Dini, E Lanino, A Garaventa, D Rogers, S Dallorso, C Viscoli, E Castagnola, G Manno, M Brisigotti, and C Rosanda |
| |
JCO Jun 1 1991: 962–969.
[Abstract]
[PDF]
|
|
|
A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix |
| |
L Souhami, RA Gil, SE Allan, PC Canary, CM Araujo, LH Pinto, and TR Silveira |
| |
JCO Jun 1 1991: 970–977.
[Abstract]
[PDF]
|
|
|
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer |
| |
M Markman, T Hakes, B Reichman, JL Lewis, Jr, S Rubin, W Jones, L Almadrones, and W Hoskins |
| |
JCO Jun 1 1991: 978–982.
[Abstract]
[PDF]
|
|
|
Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer |
| |
H Kobayashi, T Terao, and Y Kawashima |
| |
JCO Jun 1 1991: 983–987.
[Abstract]
[PDF]
|
|
|
Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma |
| |
A Recht, SM Pierce, A Abner, F Vicini, RT Osteen, SM Love, B Silver, and JR Harris |
| |
JCO Jun 1 1991: 988–996.
[Abstract]
[PDF]
|
|
|
Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data |
| |
BG Haffty, D Fischer, M Rose, M Beinfield, and C McKhann |
| |
JCO Jun 1 1991: 997–1003.
[Abstract]
[PDF]
|
|
|
A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms |
| |
JC Holland, GR Morrow, A Schmale, L Derogatis, M Stefanek, S Berenson, PJ Carpenter, W Breitbart, and M Feldstein |
| |
JCO Jun 1 1991: 1004–1011.
[Abstract]
[PDF]
|
|
|
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group |
| |
WA Bleyer, HN Sather, HJ Nickerson, PF Coccia, JZ Finklestein, DR Miller, PS Littman, JN Lukens, SE Siegel, and GD Hammond |
| |
JCO Jun 1 1991: 1012–1021.
[Abstract]
[PDF]
|
|
|
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy |
| |
WL Furman, DL Fairclough, RD Huhn, CB Pratt, N Stute, WP Petros, WE Evans, LC Bowman, EC Douglass, and VM Santana |
| |
JCO Jun 1 1991: 1022–1028.
[Abstract]
[PDF]
|
|
|
Absence of synergistic effects of CNS treatments on neuropsychologic test performance among children |
| |
RE Dowell, Jr, DR Copeland, DJ Francis, JM Fletcher, and M Stovall |
| |
JCO Jun 1 1991: 1029–1036.
[Abstract]
[PDF]
|
|
|
Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? |
| |
T Philip, JM Zucker, JL Bernard, P Lutz, P Bordigoni, E Plouvier, A Robert, H Roche, G Souillet, and E Bouffet |
| |
JCO Jun 1 1991: 1037–1044.
[Abstract]
[PDF]
|
|
|
The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma |
| |
JJ Shuster, AB Cantor, N McWilliams, JG Pole, RP Castleberry, R Marcus, T Pick, EI Smith, and FA Hayes |
| |
JCO Jun 1 1991: 1045–1049.
[Abstract]
[PDF]
|
|
|
Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma |
| |
NV Cheung and G Heller |
| |
JCO Jun 1 1991: 1050–1058.
[Abstract]
[PDF]
|
|
|
The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review |
| |
GM Kiebert, JC de Haes, and CJ van de Velde |
| |
JCO Jun 1 1991: 1059–1070.
[Abstract]
[PDF]
|
|
|
Systemic treatment of advanced and recurrent endometrial carcinoma: current status and future directions |
| |
TD Moore, PH Phillips, SR Nerenstone, and BD Cheson |
| |
JCO Jun 1 1991: 1071–1088.
[Abstract]
[PDF]
|
|
| Reprogramming SynchroMed pumps: unanticipated inaccuracy |
| WJ Hrushesky |
|
JCO Jun 1 1991: 1089–1090.
[PDF]
|
|
| Alternating combination of alkylating agents and vincristine, doxorubicin, and dexamethasone in multiple myeloma |
| C Lejeune, JJ Sotto, JG Fuzibet, JF Rossi, G Lepeu, and R Bataille |
|
JCO Jun 1 1991: 1090–1091.
[PDF]
|
|
| S-phase fraction in node-negative breast cancer |
| DE Merkel |
|
JCO Jun 1 1991: 1091–1092.
[PDF]
|
|
| Cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis |
| E Johnson |
|
JCO Jun 1 1991: 1092–1094.
[PDF]
|
|
